Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP323423.RA5_Zn8xowvEuYYNZj1X-d0mpNQT_I1ReFx4Iz22Mqn34130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP323423.RA5_Zn8xowvEuYYNZj1X-d0mpNQT_I1ReFx4Iz22Mqn34130_assertion type Assertion NP323423.RA5_Zn8xowvEuYYNZj1X-d0mpNQT_I1ReFx4Iz22Mqn34130_head.
- NP323423.RA5_Zn8xowvEuYYNZj1X-d0mpNQT_I1ReFx4Iz22Mqn34130_assertion description "[Expression of TSP-1 and TSP-2 was detected in 33 (60.0%) and 15 cases (27.3%), respectively, of 55 endometrial cancer samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323423.RA5_Zn8xowvEuYYNZj1X-d0mpNQT_I1ReFx4Iz22Mqn34130_provenance.
- NP323423.RA5_Zn8xowvEuYYNZj1X-d0mpNQT_I1ReFx4Iz22Mqn34130_assertion evidence source_evidence_literature NP323423.RA5_Zn8xowvEuYYNZj1X-d0mpNQT_I1ReFx4Iz22Mqn34130_provenance.
- NP323423.RA5_Zn8xowvEuYYNZj1X-d0mpNQT_I1ReFx4Iz22Mqn34130_assertion SIO_000772 11445843 NP323423.RA5_Zn8xowvEuYYNZj1X-d0mpNQT_I1ReFx4Iz22Mqn34130_provenance.
- NP323423.RA5_Zn8xowvEuYYNZj1X-d0mpNQT_I1ReFx4Iz22Mqn34130_assertion wasDerivedFrom befree-2016 NP323423.RA5_Zn8xowvEuYYNZj1X-d0mpNQT_I1ReFx4Iz22Mqn34130_provenance.
- NP323423.RA5_Zn8xowvEuYYNZj1X-d0mpNQT_I1ReFx4Iz22Mqn34130_assertion wasGeneratedBy ECO_0000203 NP323423.RA5_Zn8xowvEuYYNZj1X-d0mpNQT_I1ReFx4Iz22Mqn34130_provenance.